Sanofi SA
European markets head for higher open anticipating ECB rate cut; Shell and Deutsche Bank earnings on deck
European markets were set to open higher Thursday as investors await key earnings, economic data and the European Central Bank’s latest monetary policy decision. The U.K.’s FTSE 100 index is expected to open 2 points lower at 8,555, Germany’s DAX up 24 points at 21,649, France’s CAC up 25 points at 7,892 and Italy’s FTSE MIB […]
Read More
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday lowered its 2025 sales guidance by roughly $1 billion due to a few potential headwinds later this year, as the biotech company continues to cut costs and expand its portfolio. Moderna now […]
Read More
Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more
Check out the companies making headlines in midday trading: Teva Pharmaceuticals , Sanofi — Shares of Teva Pharmaceuticals and Sanofi rose more than 23% and 6%, respectively, after the companies announced positive Phase 2b results for duvakitug, their joint treatment of moderate to severe inflammatory bowel disease. Pfizer — Shares traded around 4% higher on […]
Read More
Pharma giant Sanofi opens $595 million vaccine facility in Singapore to prepare for potential pandemics
A Sanofi logo sits on the facade of the company’s headquarters on December 11, 2020 in Gentilly near Paris, France. Chesnot | Getty Images SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) “evolutive vaccine facility,” or EVF, in Singapore — the only such facility the company has […]
Read More
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read More
FTC sues drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while “artificially” inflating costs for patients. The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts. All are […]
Read More
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
New vaccine COMIRNATY® (Covid-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, California. Irfan Khan | Los Angeles Times | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! […]
Read More
FTC to sue drug middlemen over prices of medications including insulin
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. […]
Read More
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. Merck’s shot, called Capvaxive, specifically protects against 21 strains […]
Read More
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented as a stack of lawsuits relating to the discontinued heartburn drug Zantac move forward. […]
Read More